The customer observed falsely elevated active b12 results on the architect i2000sr analyzer.The following data was provided (pmol/l): (b)(6), initial 13.5, repeats 58.9, 71.9, (b)(6), initial 95.7, repeats 51.5, 19.5, (b)(6), initial 19.8, repeats 34, 45.4.There was no impact to patient management reported.
|
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, a review of labeling and review of historical data.No adverse trend was identified for the customer's issue.Labeling was reviewed and found to be adequate.The customer observed an upward shift in external control results (patient samples were used as controls) with architect active-b12 reagent lot 10366up00.An analysis utilizing field data was completed to determine if the median patient values have shifted over time.The analysis showed that the median value has not changed over time and concluded that the reagent lots included in the analysis (including likely cause lot 10366up00) read patient results consistently.Also, a review of the certificate of analysis for the likely cause lot 10366up00 and the comparison lot 10351up00 found that both lots met all specifications.Based on all available information and abbott diagnostics' complaint investigation, the assay performed as intended and no product deficiency was identified.
|